ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,945 | -26.9% | 22,750 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $49,140 | +95.0% | 22,750 | +89.6% | 0.00% | – |
| Q1 2023 | $25,200 | -10.1% | 12,000 | -6.2% | 0.00% | – |
| Q4 2022 | $28,032 | -19.9% | 12,800 | +8.5% | 0.00% | – |
| Q3 2022 | $35,000 | +12.9% | 11,800 | +9.3% | 0.00% | – |
| Q2 2022 | $31,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tikvah Management LLC | 1,225,833 | $9,157,000 | 2.55% |
| Stonepine Capital Management, LLC | 525,531 | $3,926,000 | 1.80% |
| Telemetry Investments, L.L.C. | 176,782 | $1,321,000 | 1.70% |
| TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $8,317,000 | 1.67% |
| VR Adviser, LLC | 1,565,000 | $11,691,000 | 1.60% |
| Deep Track Capital, LP | 1,100,000 | $8,217,000 | 0.58% |
| EAM Investors, LLC | 252,280 | $1,885,000 | 0.31% |
| EAM Global Investors LLC | 152,792 | $1,141,000 | 0.20% |
| FEDERATED HERMES, INC. | 5,222,250 | $39,010,000 | 0.07% |
| Alyeska Investment Group, L.P. | 674,975 | $5,042,000 | 0.06% |